Associate Professor Jakub Sedzinski Awarded ERC Grant

Associate professor Jakub Sedzinski from the Novo Nordisk Foundation for Stem Cell Medicine, reNEW

The European Research Council (ERC) has awarded Associate Professor Jakub Sedzinski, from the Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW Copenhagen node, and his team, a two million euro grant for their work on understanding how mechanical forces regulate embryo development.

“Being awarded this grant reassures us that we are on the right path, that our ideas and vision are state of the art, and that people acknowledge the importance of our research and its impact on understanding fundamental biological processes,” said Associate Professor Jakub Sedzinski.

Under the ERC project, “Morphogenesis meets Cell Fate: Dissecting how Mechanical Forces Coordinate Development,” the Sedzinski team will explore the effect of cellular activity on the formation of tissues and organs. This project centers on two key biological processes: morphogenesis, which shapes cell architectures, and cell fate acquisition, directing cells towards specialized roles. These processes work in tandem and are coordinated by mechanical forces and chemical signals within the developing tissue.

The prevailing belief regarding the processes of morphogenesis and cell fate acquisition was that the tissue environment played a dominant role in shaping the final form and function of tissues and organs. However, work by the Sedzinski group has challenged this perspective showing that, as cells undergo fate acquisition, they actively engage in remodeling the surrounding tissue within their environment. This suggests that, in the developmental process, it is not solely the tissue environment providing instructions to the cell; rather, it is both the environment and the cells themselves working together that drives the ultimate shape and function of tissues and organs.

Supported by the funds from this ERC grant, the research group will dedicate the five-year grant period to continuing their research to understand how cells interpret mechanical information, translate it into actionable responses, and subsequently communicate these responses to impact the surrounding tissue environment. The specific tissue under investigation in this project is the mucociliary epithelium, a specialized epithelial tissue found in various systems, with a particular emphasis on its role in lining the respiratory tract.

The PhDs and postdocs who will work within this group will be focussed on three major projects, combining knowledge from biophysics, engineering, computational biology and machine learning.

FORCE PROBING: Investigating the biophysical intricacies of how cells sense and reshape the tissue environment.

FORCE MODULATING: Scrutinizing the influence of mechanical forces on cell fate acquisition during development.

PREDICTING CELL FATE: Employing computational biology and machine learning to ascertain the fate of a cell solely based on its behavior.

“With this project we integrate different disciplines and approaches to deepen our understanding of tissue construction. By grasping the fundamental mechanical logic underlying our study in our simplified system, we can provide new insights into what is happening in the human airway. This knowledge enables us to characterize and comprehend the biology more effectively, but also to design engineering approaches that would aid patients with respiratory diseases in rebuilding impaired tissue,” said Associate Professor Sedzinski.

Esteemed colleagues from reNEW elected members of EMBO

The Novo Nordisk Foundation Center for Stem Cell Medicine is proud to announce that CEO and Executive Director of reNEW, Professor Mellissa H. Little and Principal Investigator at reNEW’s Copenhagen node, Professor Joshua Brickman, have this year been elected members of the prestigious European Molecular Biology Organization – EMBO.

4M euros for research into nuclear metabolism

Associate Professor Jan Żylicz from reNEW Copenhagen node, as part of an international consortium, has been awarded an MSCA Doctoral Networks Grant for project; NUCLEAR – metabolic regulation of genome function and cell identity.

The Serup Group in Copenhagen break new ground on the development of a stem cell therapy to treat diabetes

Assistant Professor Philip Seymour, former Assistant Professor Nina Funa and PhD student Heidi Mjøseng, with colleagues from the Serup Group at the Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW, University of Copenhagen, have had a paper published in Stem Cell Reports investigating further development of a cellular therapy to replace the lost insulin-producing beta cells in type one diabetics.